These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 1519573

  • 1. Reduction of portal pressure by chronic administration of isosorbide dinitrate in patients with cirrhosis: effects on systemic and splanchnic hemodynamics and liver function.
    Ikegami M, Toyonaga A, Tanikawa K.
    Am J Gastroenterol; 1992 Sep; 87(9):1160-4. PubMed ID: 1519573
    [Abstract] [Full Text] [Related]

  • 2. Nicardipine infusion improved hepatic function but failed to reduce hepatic venous pressure gradient in patients with cirrhosis.
    Iwao T, Toyonaga A, Ikegami M, Sugawara H, Sumino M, Takagi K, Oho K, Sakaki M, Ohkubo K, Inoue R.
    Am J Gastroenterol; 1992 Mar; 87(3):326-31. PubMed ID: 1539567
    [Abstract] [Full Text] [Related]

  • 3. Hemodynamic study during transdermal application of nitroglycerin tape in patients with cirrhosis.
    Iwao T, Toyonaga A, Sumino M, Takagi K, Ohkubo K, Inoue R, Tanikawa K.
    Hepatology; 1991 Jan; 13(1):124-8. PubMed ID: 1899080
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of isosorbide-5-mononitrate on variceal pressure and systemic and splanchnic haemodynamics in patients with cirrhosis.
    Escorsell A, Feu F, Bordas JM, García-Pagán JC, Luca A, Bosch J, Rodés J.
    J Hepatol; 1996 Apr; 24(4):423-9. PubMed ID: 8738728
    [Abstract] [Full Text] [Related]

  • 6. [The effect of peroral administration of isosorbide dinitrate on portal pressure and flow in patients with liver cirrhosis].
    Cervinka J, Kaláb M, Munclinger M, Kordac V, Tesar V, Marecek Z, Petrtýl J, Perlík F, Brodanová M, Ort J.
    Cas Lek Cesk; 1988 Jan 29; 127(5):140-3. PubMed ID: 3356031
    [No Abstract] [Full Text] [Related]

  • 7. Hemodynamic effects of combined treatment with somatostatin analogue (SMS 201-995) and low-dose isosorbide dinitrate on portal hypertension in conscious cirrhotic rats.
    Hori N, Okanoue T, Sawa Y, Itoh Y, Mori T, Takami S, Kashima K.
    J Gastroenterol; 1994 Aug 29; 29(4):460-8. PubMed ID: 7951857
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Duplex Doppler ultrasonography allows a multiorgan noninvasive approach to splanchnic pharmacodynamics in patients with cirrhosis.
    Bolognesi M, Sacerdoti D, Merkel C, Caregaro L, Bellon S, Gatta A.
    Bildgebung; 1995 Jun 29; 62(2):138-43. PubMed ID: 7663138
    [Abstract] [Full Text] [Related]

  • 11. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
    Merkel C, Finucci G, Zuin R, Bazzerla G, Bolognesi M, Sacerdoti D, Gatta A.
    J Hepatol; 1987 Apr 29; 4(2):174-80. PubMed ID: 3584925
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [The effects of cimetidine on splanchnic hemodynamics in cirrhotic patients with portal hypertension].
    Li S.
    Zhonghua Wai Ke Za Zhi; 1993 Apr 29; 31(4):207-9. PubMed ID: 8275833
    [Abstract] [Full Text] [Related]

  • 14. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG, Albillos A, Bañares R, Turnes J, González R, García-Pagán JC, Bosch J.
    Gastroenterology; 2009 May 29; 136(5):1651-8. PubMed ID: 19208350
    [Abstract] [Full Text] [Related]

  • 15. Oral administration of nipradilol and the acute and chronic splanchnic hemodynamic effects of a new beta-blocker with nitrovasodilating properties in patients with liver cirrhosis.
    Sugano S, Kawafune T, Suzuki T, Kubota M, Okajima T, Sumino Y, Akita H.
    Am J Gastroenterol; 1995 May 29; 90(5):788-93. PubMed ID: 7733089
    [Abstract] [Full Text] [Related]

  • 16. Disagreement between acute and chronic haemodynamic effects of nadolol in cirrhosis: a pathophysiological interpretation.
    Merkel C, Bolognesi M, Sacerdoti D, Bombonato G, Cavasin L, Gatta A.
    Aliment Pharmacol Ther; 2005 Sep 01; 22(5):433-9. PubMed ID: 16128681
    [Abstract] [Full Text] [Related]

  • 17. Propranolol compared with propranolol plus isosorbide dinitrate in portal-hypertensive patients: long-term hemodynamic and renal effects.
    Vorobioff J, Picabea E, Gamen M, Villavicencio R, Bordato J, Bessone F, Tanno H, Palazzi J, Sarano H, Pozzoli L.
    Hepatology; 1993 Sep 01; 18(3):477-84. PubMed ID: 8359793
    [Abstract] [Full Text] [Related]

  • 18. Effects of ritanserin, a selective and specific S2-serotonergic antagonist, on portal pressure and splanchnic hemodynamics in rats with long-term bile duct ligation.
    Fernández M, Pizcueta P, García-Pagán JC, Feu F, Cirera I, Bosch J, Rodés J.
    Hepatology; 1993 Aug 01; 18(2):389-93. PubMed ID: 8340068
    [Abstract] [Full Text] [Related]

  • 19. Hemodynamic effects of alpha-adrenergic blockade with prazosin in cirrhotic patients with portal hypertension.
    Albillos A, Lledó JL, Bañares R, Rossi I, Iborra J, Calleja JL, Garrido A, Escartin P, Bosch J.
    Hepatology; 1994 Sep 01; 20(3):611-7. PubMed ID: 7915703
    [Abstract] [Full Text] [Related]

  • 20. Effect of vardenafil, an inhibitor of phosphodiesterase-5, on portal haemodynamics in normal and cirrhotic liver -- results of a pilot study.
    Deibert P, Schumacher YO, Ruecker G, Opitz OG, Blum HE, Rössle M, Kreisel W.
    Aliment Pharmacol Ther; 2006 Jan 01; 23(1):121-8. PubMed ID: 16393289
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.